Medicines and life (to the 100th anniversary of Professor Irina Vitalievna Zaikonnikova)

Abstract

Irina Vitalevna Zaikonnikova is a well-known Soviet pharmacologist, headed the Department of Pharmacology of the Kazan State Medical Institute between 1968 and 1989. The topic of I.V. Zaikonnikova’s Ph.D. thesis was “The influence of dikain on blood vessels and its relationship with adrenaline”. In her dissertation, Irina Vitalievna found that dicaine dilates blood vessels in low concentrations and causes their constriction in high concentrations. The thesis was successfully defended in 1947. In the 50s of the last century in Kazan, for the first time in the Soviet Union, the study of the biological activity of organophosphorus compounds was begun. A large experimental material concerning the correlation between the biological activity and chemical structure of compounds was summarized in his doctoral dissertation “Pharmacological characteristics of a number of dialkylphosphinic acid esters”, which I.V. Zaikonnikova defended in 1968. At the Department of Pharmacology, which she headed since 1968, a close-knit team was formed, united by a common interest — the search and development of new potential drugs. This major work resulted in the creation of cidiphos, glycifon, phosphabenzide, and dimephosphon — organophosphorus compounds of a new type, which mechanism of action is not associated with inhibition of the activity of acetylcholinesterase. In addition, drugs that did not belong to organophosphates were created — the daytime tranquilizer mebikar, a regeneration stimulator with the immunomodulatory effect of xymedon. At present, the Department of Pharmacology of Kazan State Medical University continues the scientific traditions of our outstanding predecessors.

Keywords

I.V. Zaikonnikova / Pharmacology / Department of Pharmacology / Kazan State Medical University

References

[1] Aluf M.A. To the pharmacology of armin. Farmakologiya i toksikologiya. 1955; 18: 21–27. (In Russ.)

[2] Алуф М.А. К фармакологии армина. Фармакол. и токсикол. 1955; 18: 21–27.

[3] Afonskaya L.S., Zaikonnikova I.V., Rzhevskaya G.F., Studentsova I.A. To the mechanism of action of armin and nibufin. Farmakologiya i toksikologiya. 1963; 26: 184–189. (In Russ.)

[4] Афонская Л.С., Заиконникова И.В., Ржевская Г.Ф., Студенцова И.А. К механизму действия армина и нибуфина. Фармакол. и токсикол. 1963; 26: 184–189.

[5] Garayev R.S. The search for new organophosphorus drugs is the leading direction of scientific research of the Department of Pharmacology of KSMU. Kazan Medical Journal. 2008; 89: 585–590. (In Russ.)

[6] Гараев Р.С. Изыскание новых лекарственных средств в рядах фосфорорганических соединений — ведущее направление научных исследований кафедры фармакологии КГМУ. Казанский мед. ж. 2008; 89: 585–590.

[7] Studentsova I.A., Garayev R.S. Toxicity and some biological effects of organophosphorus epoxides. Eksperimental'naya i klinicheskaya farmakologiya. 1996; 59: 31–33. (In Russ.)

[8] Студенцова И.А., Гараев Р.С. Токсичность и некоторые биологические эффекты фосфорорганических эпоксидов. Эксперим. и клин. фармакол. 1996; 59: 31–33.

[9] Ga¬raev R.S., Gilmutdinova V.R., Zalyalyutdinova L.N., Khasanov R.Sh. Long-term results of treatment of basal cell cancer with glitsifon ointment. Kazan Medical Journal. 2010; 91: 511–515. (In Russ.)

[10] Гараев Р.С., Гильмутдинова В.Р., Залялютдинова Л.Н., Хасанов Р.Ш. Отдалённые результаты лечения больных базально-клеточным раком глицифоновой мазью. Казанский мед. ж. 2010; 91: 511–515.

[11] Semina I.I., Baychurina A.Z. Development of new potential drugs with psychotropic activity among phosphorylacetohydrazides and other phosphorylated carboxylic acids derivatives — priority area of kazan school of psychopharmacologists. Kazan Medical Journal. 2016; 97: 148–155. (In Russ.) DOI: 10.17750/KMJ2016-148.

[12] Сёмина И.И., Байчурина А.З. Разработка новых потенциальных лекарственных средств с психотропной активностью среди фосфорилацетогидразидов и других производных фосфорилированных карбоновых кислот — приоритетное направление казанской школы психофармакологов. Казанский мед. ж. 2016; 97: 148–155. DOI: 10.17750/KMJ2016-148.

[13] Pikuza O.I., Zaikonnikova I.V., Studentsova I.A., Aleksandrova L.Ya. Experience of using dimephosphone in the complex therapy of pneumonia in newborns. Pediatriya. 1989; (3): 39–41. (In Russ.)

[14] Пикуза О.И., Заиконникова И.В., Студенцова И.А., Александрова Л.Я. Опыт применения димефосфона в комплексной терапии пневмонии у новорождённых. Педиатрия. 1989; (3): 39–41.

[15] Ziganshina L.E., Studentsova I.A., Ziganshin A.U., Valeyeva I.Kh. The mechanism of action of dimephosphone. Eksperimental'naya i klinicheskaya farmakologiya. 1992; 55: 43–45. (In Russ.)

[16] Зиганшина Л.Е., Студенцова И.А., Зиганшин А.У., Валеева И.Х. Механизм действия димефосфона. Эксперим. и клин. фармакол. 1992; 55: 43–45.

[17] Kamburg R.A., Zaikonnikova I.V. Results of an experimental study and clinical use of the tranquilizer mebikar. Farmakologiya i toksikologiya. 1986; 49: 89–91. (In Russ.)

[18] Камбург Р.А., Заиконникова И.В. Результаты экспериментального исследования и клинического применения транквилизатора мебикар. Фармакол. и токсикол. 1986; 49: 89–91.

[19] Tsibul'kin A.P., Slabnov Yu.D., Pozdeyev O.K., Cherepnev G.V., Garayev R.S., Ismayev Kh.I. Modeling the expression of key molecules of membranes of immunocompetent cells by pyrimidine derivatives: substantiation of the systemic nature of the immunopotentiating effect. Immunologiya. 1998; (4): 29–33. (In Russ.)

[20] Цибулькин А.П., Слабнов Ю.Д., Поздеев О.К., Черепнёв Г.В., Гараев Р.С., Исмаев Х.И. Моделирование экспрессии ключевых молекул мембран иммунокомпетентных клеток пиримидиновыми производными: обоснование системности иммунопотенцирующего эффекта. Иммунология. 1998; (4): 29–33.

[21] Cherepnev G.V., Garayev R.S., Tereshchenko V.Yu., Malyshev K.V. Immunomodulator Ximedon Reduces the Level of Induced DNA Damage in Bone Marrow and Peripheral Blood Cells: Possibilities of Immunogenetic Correction. Eksperimental'naya i klinicheskaya farmakologiya. 1999; 62: 31–35. (In Russ.)

[22] Черепнёв Г.В., Гараев Р.С., Терещенко В.Ю., Малышев К.В. Иммуномодулятор ксимедон снижает уровень индуцированных повреждений ДНК в клетках костного мозга и периферической крови: возможности иммуногенетической коррекции. Эксперим. и клин. фармакол. 1999; 62: 31–35.

[23] Garayev R.S., Studentsova I.A. In memory of Irina Vitalievna Zaikonnikova. Eksperimental'naya i klinicheskaya farmakologiya. 1996; 59: 74. (In Russ.)

[24] Гараев Р.С., Студенцова И.А. Памяти Ирины Витальевны Заиконниковой. Эксперим. и клин. фармакол. 1996; 59: 74.

RIGHTS & PERMISSIONS

Eco-Vector